✦ LIBER ✦

Pemetrexed in pancreatic cancer

✍ Scribed by Hedy Lee Kindler

Book ID: 114105482
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 74 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(02)70046-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed improves survival in pancreat

Pemetrexed improves survival in pancreatic cancer

✍ Li Wan 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 47 KB

The pemetrexed/gemcitabine combination i

The pemetrexed/gemcitabine combination in pancreatic cancer

✍ Hedy Lee Kindler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Gemcitabine has modest antitumor activity in advanced pancreatic cancer. New agents are clearly needed. Pemetrexed (ALIMTA) is a novel antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed has shown in vitro activity agai

Pemetrexed: Translational research in br

Pemetrexed: Translational research in breast cancer

✍ Axel R Hanauske 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Use of Pemetrexed in Breast Cancer

✍ Christian Dittrich 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Pemetrexed (Alimta) in small cell lung c

Pemetrexed (Alimta) in small cell lung cancer

✍ Mark A. Socinski 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Clinical Experience With Pemetrexed in B

Clinical Experience With Pemetrexed in Breast Cancer

✍ Miguel Martin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB